An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
29 04 2020
Historique:
received: 05 03 2020
accepted: 03 04 2020
pubmed: 8 4 2020
medline: 6 5 2020
entrez: 8 4 2020
Statut: ppublish

Résumé

Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19. Here, we show that the ribonucleoside analog β-d-N

Identifiants

pubmed: 32253226
pii: scitranslmed.abb5883
doi: 10.1126/scitranslmed.abb5883
pmc: PMC7164393
pii:
doi:

Substances chimiques

Antiviral Agents 0
Hydroxylamines 0
RNA, Viral 0
Ribonucleosides 0
remdesivir 3QKI37EEHE
Adenosine Monophosphate 415SHH325A
Cytidine 5CSZ8459RP
N(4)-hydroxycytidine C3D11PV2O4
RNA-Dependent RNA Polymerase EC 2.7.7.48
Alanine OF5P57N2ZX
molnupiravir YA84KI1VEW

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201500008C
Pays : United States
Organisme : NIAID NIH HHS
ID : F31 AI133952
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI108197
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI112541
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142759
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI132178
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK065988
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109680
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Références

Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891600
Sci Rep. 2017 Mar 06;7:43395
pubmed: 28262699
Nucleic Acids Res. 2006;34(22):6438-49
pubmed: 17130163
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
PLoS One. 2015 Jun 26;10(6):e0131451
pubmed: 26115403
Nat Microbiol. 2016 Nov 28;2:16226
pubmed: 27892925
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137799
J Crit Care. 2020 Jun;57:279-283
pubmed: 32173110
Methods Mol Med. 2005;107:183-206
pubmed: 15492373
Virology. 2004 Dec 5;330(1):8-15
pubmed: 15527829
J Virol. 2005 Dec;79(24):15511-24
pubmed: 16306622
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603
pubmed: 24062443
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Virology. 2018 Apr;517:98-107
pubmed: 29277291
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Clin Infect Dis. 2011 Feb 15;52(4):457-65
pubmed: 21220768
Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
pubmed: 21531958
J Virol. 2019 Nov 26;93(24):
pubmed: 31578288
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20166-71
pubmed: 22135472
mBio. 2013 Sep 10;4(5):e00650-13
pubmed: 24023385
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Virol. 2018 Jan 17;92(3):
pubmed: 29167335
J Virol. 2002 Nov;76(21):11065-78
pubmed: 12368349
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Virology. 2006 Jul 20;351(1):180-7
pubmed: 16647731
J Virol. 2012 Dec;86(23):12816-25
pubmed: 22993147
Methods Mol Biol. 2013;945:109-21
pubmed: 23097104
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Nature. 2018 Apr;556(7700):255-258
pubmed: 29618817
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Antiviral Res. 2019 Sep;169:104541
pubmed: 31233808
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19944-9
pubmed: 19036930
mBio. 2017 Apr 4;8(2):
pubmed: 28377531
Viruses. 2019 Apr 04;11(4):
pubmed: 30987343
Nat Commun. 2019 May 28;10(1):2342
pubmed: 31138817
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
PLoS One. 2011;6(6):e21207
pubmed: 21701593
mBio. 2018 Mar 6;9(2):
pubmed: 29511076
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
mBio. 2014 Mar 25;5(2):e00047-14
pubmed: 24667706
Viruses. 2015 Dec 01;7(12):6233-40
pubmed: 26633464
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
pubmed: 26976607
PLoS Pathog. 2018 Feb 9;14(2):e1006889
pubmed: 29425244
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16157-62
pubmed: 24043791
J Virol. 2015 Aug;89(16):8540-55
pubmed: 26041299
J Virol. 2011 Jan;85(1):217-30
pubmed: 20980507
Nature. 2016 Mar 17;531(7594):381-5
pubmed: 26934220
Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645453
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
PLoS Pathog. 2007 Jan;3(1):e5
pubmed: 17222058
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
PLoS Pathog. 2013 Aug;9(8):e1003565
pubmed: 23966862
Sci Transl Med. 2014 Sep 10;6(253):253ps10
pubmed: 25210060
Virol J. 2015 Dec 22;12:221
pubmed: 26689940
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
N Engl J Med. 2016 Sep 29;375(13):1303-5
pubmed: 27682053
Emerg Infect Dis. 2003 Jun;9(6):713-7
pubmed: 12781012
PLoS Pathog. 2018 Jan 2;14(1):e1006810
pubmed: 29293660

Auteurs

Timothy P Sheahan (TP)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. sheahan@email.unc.edu rbaric@email.unc.edu.

Amy C Sims (AC)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Shuntai Zhou (S)

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Rachel L Graham (RL)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Andrea J Pruijssers (AJ)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Maria L Agostini (ML)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Sarah R Leist (SR)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Alexandra Schäfer (A)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Kenneth H Dinnon (KH)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Laura J Stevens (LJ)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

James D Chappell (JD)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Xiaotao Lu (X)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Tia M Hughes (TM)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Amelia S George (AS)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Collin S Hill (CS)

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Stephanie A Montgomery (SA)

Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

Ariane J Brown (AJ)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Gregory R Bluemling (GR)

Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA 30322, USA.
Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.

Michael G Natchus (MG)

Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA 30322, USA.

Manohar Saindane (M)

Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA 30322, USA.

Alexander A Kolykhalov (AA)

Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA 30322, USA.
Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.

George Painter (G)

Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA 30322, USA.
Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.
Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA.

Jennifer Harcourt (J)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Azaibi Tamin (A)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Natalie J Thornburg (NJ)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Ronald Swanstrom (R)

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Mark R Denison (MR)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Ralph S Baric (RS)

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. sheahan@email.unc.edu rbaric@email.unc.edu.
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH